Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Recruiting 3Active not recruiting 3Completed 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma, Large B-Cell, Diffuse 14Lymphoma 12Burkitt Lymphoma 12Neoplasms 8Lymphoma, Follicular 8Lymphoma, B-Cell 6Rhabdomyosarcoma 5Medulloblastoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Hodgkin Disease 4Retinoblastoma 3Recurrence 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma, B-Cell, Marginal Zone 3Central Nervous System Neoplasms 3Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2Rhabdoid Tumor 2Neuroectodermal Tumors, Primitive 2Lymphoproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma, AIDS-Related 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2Leukemia 2

Interventions

Vincristine 3Dexamethasone 3Cyclophosphamide 3blinatumomab 2Prednisone 2Methylprednisolone 2Methotrexate 2Mercaptopurine 2Doxorubicin 2Cytarabine 2venetoclax 1prednylidene 1pegaspargase 1merphos 1fludarabine phosphate 1fludarabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1azathiopurine 1auricularum 1asparaginase erwinia chrysanthemi recombinant 1Thioguanine 1Spinal Puncture 1Specimen Handling 1Rituximab 1Radiotherapy 1Radiation 1Prednisolone 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Vincristine × Clear all
NCT03504644 2026-05-29

Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia

Eastern Cooperative Oncology Group

Phase 1/2 Active not recruiting
40 enrolled 18 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03914625 2026-05-27

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 3 Active not recruiting
6,720 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Down Syndrome, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

NCT05303792 2026-04-07

Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
68 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡